EDGAR Filing Documents for 0001193125-19-014088

Form 8-K - Current report:

SEC Accession No. 0001193125-19-014088

Filing Date

2019-01-22

Accepted

2019-01-22 17:08:35

Documents

Period of Report

2019-01-22

Items

Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	d665822d8k.htm	8-K	18059
2	EX-99.1	d665822dex991.htm	EX-99.1	10322
3	EX-99.2	d665822dex992.htm	EX-99.2	396714
4	GRAPHIC	g665822g29l09.jpg	GRAPHIC	2750
5	GRAPHIC	g665822osm_capture2.jpg	GRAPHIC	34629
	Complete submission text file	0001193125-19-014088.txt		472738

Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007

Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601

UroGen Pharma Ltd. (Filer) CIK: 0001668243 (see all company filings)